CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 227 filers reported holding CORCEPT THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.47 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $373,747 | +22.4% | 13,718 | 0.0% | 0.00% | +100.0% |
| Q2 2023 | $305,226 | +2.7% | 13,718 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $297,132 | +27.7% | 13,718 | +19.8% | 0.00% | 0.0% |
| Q4 2022 | $232,651 | -30.1% | 11,455 | -11.7% | 0.00% | -50.0% |
| Q3 2022 | $333,000 | +7.8% | 12,977 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $309,000 | -11.0% | 12,977 | -15.8% | 0.00% | 0.0% |
| Q1 2022 | $347,000 | +13.8% | 15,416 | 0.0% | 0.00% | +100.0% |
| Q4 2021 | $305,000 | +25.5% | 15,416 | +25.0% | 0.00% | 0.0% |
| Q3 2021 | $243,000 | -10.3% | 12,334 | 0.0% | 0.00% | -50.0% |
| Q2 2021 | $271,000 | -7.5% | 12,334 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $293,000 | -28.2% | 12,334 | -20.8% | 0.00% | 0.0% |
| Q4 2020 | $408,000 | +50.6% | 15,582 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $271,000 | +3.4% | 15,582 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $262,000 | +178.7% | 15,582 | +98.1% | 0.00% | +100.0% |
| Q1 2020 | $94,000 | +28.8% | 7,864 | +30.7% | 0.00% | 0.0% |
| Q4 2019 | $73,000 | -14.1% | 6,015 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $85,000 | +26.9% | 6,015 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $67,000 | -5.6% | 6,015 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $71,000 | -9.0% | 6,015 | +2.6% | 0.00% | 0.0% |
| Q4 2018 | $78,000 | -4.9% | 5,862 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $82,000 | +1.2% | 5,862 | +13.1% | 0.00% | 0.0% |
| Q2 2018 | $81,000 | -4.7% | 5,183 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $85,000 | -9.6% | 5,183 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $94,000 | +70.9% | 5,183 | +80.4% | 0.00% | 0.0% |
| Q3 2017 | $55,000 | +61.8% | 2,873 | 0.0% | 0.00% | – |
| Q2 2017 | $34,000 | +9.7% | 2,873 | 0.0% | 0.00% | – |
| Q1 2017 | $31,000 | +47.6% | 2,873 | 0.0% | 0.00% | – |
| Q4 2016 | $21,000 | +40.0% | 2,873 | +23.9% | 0.00% | – |
| Q3 2016 | $15,000 | +15.4% | 2,319 | 0.0% | 0.00% | – |
| Q2 2016 | $13,000 | +18.2% | 2,319 | 0.0% | 0.00% | – |
| Q1 2016 | $11,000 | -8.3% | 2,319 | 0.0% | 0.00% | – |
| Q4 2015 | $12,000 | +33.3% | 2,319 | 0.0% | 0.00% | – |
| Q3 2015 | $9,000 | – | 2,319 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 8,712,176 | $123,147,000 | 6.01% |
| TANAKA CAPITAL MANAGEMENT INC | 74,139 | $1,048,000 | 3.38% |
| S&T BANK/PA | 625,078 | $8,859,000 | 1.92% |
| Parallel Advisors, LLC | 1,277,851 | $18,062,000 | 1.55% |
| AJ WEALTH STRATEGIES, LLC | 595,828 | $8,422,000 | 1.11% |
| Matarin Capital Management, LLC | 891,636 | $12,603,000 | 0.95% |
| Capital Impact Advisors, LLC | 162,544 | $2,370,000 | 0.90% |
| AMI ASSET MANAGEMENT CORP | 775,685 | $10,964,000 | 0.57% |
| Birchview Capital, LP | 50,000 | $707,000 | 0.47% |
| Zebra Capital Management LLC | 25,409 | $359,000 | 0.39% |